Appleton Group, LLC Bluebird Bio, Inc. Transaction History

Appleton Group, LLC

  • $28.6 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$8.96 - $16.31 $174,675 - $317,963
-19,495 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$11.24 - $21.0 $91,819 - $171,549
8,169 Added 72.13%
19,495 $373,000
Q2 2021

Aug 05, 2021
BUY
$18.04 - $22.09 $204,321 - $250,191
11,326 New
11,326 $362,000

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Appleton Group, LLC Portfolio

Follow Appleton Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email